Laboratory-based evaluation of the colorimetric VITEK-2 Compact system for species identification and of the Advanced Expert System for detection of antimicrobial resistances: VITEK-2 Compact system identification and antimicrobial susceptibility testing.

The newly redesigned colorimetric VITEK-2 Compact system with updated Advanced Expert System (AES) (bioMerieux, Marcy l'Etoile, France) was evaluated for its accuracy and rapidity to identify clinical isolates and to detect several antimicrobial resistances. Overall, the VITEK-2 gave 95.8% of compatibility with the reference API strips (bioMerieux) in the identifications (IDs) of Gram-positive cocci (GPC), Gram-negative rods (GNR), and yeasts. The accuracy was finally estimated to 98.3% through additional confirmatory tests. Also, >90% of IDs of GPC and GNR were obtained within 7 h of incubations. The VITEK AES correctly detected 97.7% of antimicrobial resistances, including extended-spectrum beta-lactamases, oxacillin and inducible clindamycin resistances in staphylococci, vancomycin resistance in enterococci, and penicillin and erythromycin resistances in Streptococcus pneumoniae. The most resistant isolates were identified within 12 h of incubations. In conclusion, the new colorimetric VITEK-2 Compact system with AES greatly improved its accuracy in species ID and detection of antimicrobial resistances, and it will be highly acceptable to clinical microbiology laboratory function.

[1]  N Woodford,et al.  Current perspectives on glycopeptide resistance , 1995, Clinical microbiology reviews.

[2]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[3]  F. Tenover,et al.  Characterization of glycopeptide-resistant enterococci from U.S. hospitals , 1993, Antimicrobial Agents and Chemotherapy.

[4]  K. Sunakawa,et al.  In vitro activities of new ketolide, telithromycin, and eight other macrolide antibiotics against Streptococcus pneumoniae having mefA and ermB genes that mediate macrolide resistance , 2003, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[5]  G. Funke,et al.  Evaluation of the New VITEK 2 Card for Identification of Clinically Relevant Gram-Negative Rods , 2004, Journal of Clinical Microbiology.

[6]  S. Khan,et al.  Simultaneous detection of erythromycin-resistant methylase genes ermA and ermC from Staphylococcus spp. by multiplex-PCR. , 1999, Molecular and cellular probes.

[7]  K. Ubukata,et al.  Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR , 1996, Journal of clinical microbiology.

[8]  H. Rohde,et al.  Rapid Detection of Methicillin Resistance in Coagulase-Negative Staphylococci by a Penicillin-Binding Protein 2a-Specific Latex Agglutination Test , 2001, Journal of Clinical Microbiology.

[9]  Kenneth S. Thomson,et al.  Ability of the VITEK 2 Advanced Expert System To Identify β-Lactam Phenotypes in Isolates of Enterobacteriaceae andPseudomonas aeruginosa , 2000, Journal of Clinical Microbiology.

[10]  J. Warren,et al.  Evaluation of the Vitek 2 System for Rapid Identification of Clinical Isolates of Gram-Negative Bacilli and Members of the Family Streptococcaceae , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[11]  K. Ko,et al.  High frequency of vancomycin-resistant Enterococcus faecium isolates with VanB phenotype and vanA genotype in Korean hospitals. , 2006, Diagnostic microbiology and infectious disease.

[12]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[13]  T Ezaki,et al.  Streptococcus peroris sp. nov. and Streptococcus infantis sp. nov., new members of the Streptococcus mitis group, isolated from human clinical specimens. , 1998, International journal of systematic bacteriology.

[14]  D. Larone,et al.  Comparative Study of the New Colorimetric VITEK 2 Yeast Identification Card versus the Older Fluorometric Card and of CHROMagar Candida as a Source Medium with the New Card , 2006, Journal of Clinical Microbiology.

[15]  Y. Arakawa,et al.  A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. , 2000, FEMS microbiology letters.

[16]  D. Volokhov,et al.  Microarray analysis of erythromycin resistance determinants , 2003, Journal of applied microbiology.

[17]  G. Funke,et al.  Performance of the New VITEK 2 GP Card for Identification of Medically Relevant Gram-Positive Cocci in a Routine Clinical Laboratory , 2005, Journal of Clinical Microbiology.

[18]  K. Schleifer,et al.  Recent Changes in the Classification of the Pseudomonads: an Overview , 1996 .

[19]  T Ezaki,et al.  Determination of 16S rRNA sequences of Streptococcus mitis and Streptococcus gordonii and phylogenetic relationships among members of the genus Streptococcus. , 1995, International journal of systematic bacteriology.

[20]  L. Martínez-Martínez,et al.  Evaluation of the VITEK 2 System for the Identification and Susceptibility Testing of Three Species of Nonfermenting Gram-Negative Rods Frequently Isolated from Clinical Samples , 2001, Journal of Clinical Microbiology.

[21]  S. Messier,et al.  Identification of Catalase-Negative, Non-Beta-Hemolytic, Gram-Positive Cocci Isolated from Milk Samples , 2003, Journal of Clinical Microbiology.

[22]  J. Barry,et al.  Comparative evaluation of the VITEK 2 Advanced Expert System (AES) in five UK hospitals. , 2003, The Journal of antimicrobial chemotherapy.

[23]  M. Cavassini,et al.  Evaluation of MRSA-Screen, a Simple Anti-PBP 2a Slide Latex Agglutination Kit, for Rapid Detection of Methicillin Resistance in Staphylococcus aureus , 1999, Journal of Clinical Microbiology.